Arbutus Biopharma Down Over 14%, on Pace for Largest Percent Decrease Since July 2020 -- Data Talk

Dow Jones
Jan 17

Arbutus Biopharma Corporation (ABUS) is currently at $4.04, down $0.67 or 14.15%

 

--Would be lowest close since Sept. 4, 2025, when it closed at $4.01

--On pace for largest percent decrease since July 24, 2020, when it fell 20%

--Currently down two consecutive days; down 15.59% over this period

--Worst two day stretch since the two days ending April 25, 2023, when it fell 15.67%

--Down 12.66% this week; worst weekly performance since the week ending April 28, 2023, when it fell 16.33%

--Down 16.11% month-to-date

--Down 16.11% year-to-date

--Down 86.96% from its all-time closing high of $30.94 on March 11, 2014

--Up 26.09% from 52 weeks ago (Jan. 17, 2025), when it closed at $3.20

--Down 18.48% from its 52-week closing high of $4.95 on Dec. 15, 2025

--Up 40.1% from its 52-week closing low of $2.88 on April 8, 2025

--Traded as low as $3.68; lowest intraday level since Sept. 2, 2025, when it hit $3.66

--Down 21.7% at today's intraday low; largest intraday percent decrease since July 24, 2020, when it fell as much as 23.06%

 

All data as of 12:15:23 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

January 16, 2026 12:21 ET (17:21 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10